Davis Capital Management’s ADMA Biologics ADMA Stock Holding History

Davis Capital Management’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$109	Buy	+13	New	+$119	﹤0.01%	1040

Other funds holding ADMA

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS)

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Davis Capital Management's ADMA Position: Q2 2026 in Review

Davis Capital Management opened a new position in ADMA Biologics (ADMA) in Q2 2026: 13 shares worth $109. The stake represents ﹤0.01% of the portfolio and ranks #1040 among its holdings.

62 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

Davis Capital Management held 13 shares of ADMA Biologics worth $109 as of Q2 2026.
ADMA Biologics was a new Davis Capital Management position in Q2 2026.
ADMA Biologics made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #1040 holding.
62 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.